Amol Nirgudkar, CEO of Patient Prism, returns to the show to talk about why new patients are worth so much more than existing patients, why even big DSOs so often struggle with marketing, and why now is not the time to stop investing in growth.
Guest Info
Amol Nirgudkar
CEO at Patient Prism
LinkedIn
Facebook
Instagram
YouTube
Twitter
Say hello to Amol!
